What are the Challenges in Using Small Molecule Drugs in Pediatrics?
One of the primary challenges is the lack of extensive clinical trials specifically conducted in pediatric populations. Most drugs are initially tested in adults, and their use in children requires careful extrapolation of dosing and safety data. Additionally, children have different metabolic pathways and organ maturation rates, which can affect drug absorption, distribution, metabolism, and excretion.
